4//SEC Filing
Strobeck Matthew 4
Accession 0000905148-24-001143
CIK 0001439725other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 7:36 PM ET
Size
9.0 KB
Accession
0000905148-24-001143
Insider Transaction Report
Form 4
BIODESIX INCBDSX
Strobeck Matthew
Director
Transactions
- Award
Series A Non-Voting Convertible Preferred Stock
2024-04-05$46.00/sh+1,304$59,984→ 1,304 total(indirect: By Birchview Capital Separately Managed Account)→ Common Stock (52,160 underlying) - Award
Series A Non-Voting Convertible Preferred Stock
2024-04-05$46.00/sh+7,392$340,032→ 7,392 total(indirect: By LLC)→ Common Stock (295,680 underlying)
Footnotes (2)
- [F1]These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the "Conversion Proposal"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date.
- [F2]The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
BIODESIX INC
CIK 0001439725
Entity typeother
Related Parties
1- filerCIK 0001377832
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 7:36 PM ET
- Size
- 9.0 KB